![]() ![]() When funicular myelosis, amyotrophic lateral sclerosis can be introduced into the spinal canal at 15-30 mcg, gradually increasing the dose of 200-250 micrograms. When hepatitis and cirrhosis - 30-60 mcg / day or 100 mg every other day for 25-40 days.ĭystrophy in young children, Down syndrome and cerebral palsy - by 15-30 mcg every other day. In traumatic lesions of peripheral nervous system - at 200-400 mcg every other day for 40-45 days. The course of treatment with Nucleo CMP (Vitamin B12 (Hydroxocobalamin)) is 2 weeks. In diseases of the central and peripheral nervous system and neurological diseases with a pain syndrome is administered in increasing doses - 200-500 mcg, with the improvement in the state - 100 mcg / day. When nutritional anemia in infants and preterm - 30 mcg / day during 15 days. ![]() When aplastic anemia (especially in children) - 100 micrograms before clinical improvement. In acute post-hemorrhagic anemia and iron anemia by 30-100 mcg 2-3 times a week. In the period of remission in the absence of events funicular myelosis maintenance dose - 100 mcg 2 times a month, in the presence of neurological symptoms - at 200-400 mcg 2-4 times a month. In anemia with symptoms of funicular myelosis and megalocytic anemia with diseases of the nervous system - 400-500 micrograms in the first 7 days daily, then 1 time every 5-7 days. With anemia associated with Nucleo CMP (Vitamin B12 (Hydroxocobalamin)) deficiency is introduced on 100-200 mcg in 2 days. Nucleo CMP ) is used as injections SC, IV, IM, intralumbar, and also oral. Excreted in bile and urine.Īnemia due to B12-deficiency conditions in the complex therapy for iron and posthemorrhagic anemia aplastic anemia caused by toxic substances and drugs liver disease (hepatitis, cirrhosis) funicular myelosis polyneuritis, radiculitis, neuralgia, amyotrophic lateral sclerosis children cerebral palsy, Down syndrome, peripheral nerve injury skin diseases (psoriasis, photodermatosis, herpetiformis dermatitis, neurodermatitis) to prevent and treat symptoms of deficiency of Nucleo CMP (Vitamin B12 (Hydroxocobalamin)) (including the application of biguanide, PASA, vitamin C in high doses) radiation sickness. Metabolized in the tissues, becoming a co-enzyme form - adenosylcobalamin which is the active form of cyanocobalamin. Activates the coagulation of blood in high doses causes an increase in the activity of thromboplastin and prothrombin.Īfter oral administration Nucleo CMP (Vitamin B12 (Hydroxocobalamin)) absorbed from the gastrointestinal tract. Has a beneficial effect on liver function and the nervous system. ![]() Contributes to the accumulation in erythrocytes of compounds containing sulfhydryl groups. Involved in the processes of transmethylation, hydrogen transport, synthesis of methionine, nucleic acids, choline, creatine. Nucleo CMP (Vitamin B12 (Hydroxocobalamin)) is necessary for normal hematopoiesis (promotes maturation of erythrocytes). According to the WHO, 817 clinical studies are currently conducted in Lebanon.Nucleo CMP ) refers to a group of water-soluble vitamins. Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. Ixempra, a medicinal product withdrawn in Europe is imported to lebanonĪ vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon Some Non-Marketed medicines are still imported The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein The price of the most expensive medicine available in Lebanon is 30434557 LLĪt least 1309 medicinal products are more expensive in Lebanon than in the countries of originĭaktavira, a generic of Daklinza, is registered in Lebanon but has no public priceģ52 medicinal products have been declared as non-marketed or withdrawnĦ4.72% of lebanese pharmacists are femaleĤ86 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date In Lebanon, 88 generic medicinal products are more expensive than their OriginatorsĪ medicinal product refused in Europe is marketed in LebanonĪt least 332 medicinal products are available on the Lebanese market and are not available in the country of origin 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical RepresentativeĢ16 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |